MEG3 and colorectal carcinoma: It was proven that some of these forms of RNA (e.g., lncRNAs 91H, PVT-1, and MEG3) can serve as biomarkers of improved sensitivity in early-stage CRC compared to the combination of CEA and CA19-9—the biomarkers currently used for CRC detection [42].